Valuation: Incyte Corporation

Market Cap 23.51B 20.65B 19.2B 17.62B 33.11B 2,264B 33.62B 228B 89.08B 1,113B 88.25B 86.35B 3,848B P/E 2026 *
57x
P/E 2027 * 15.3x
Enterprise Value 19.5B 17.13B 15.93B 14.62B 27.46B 1,878B 27.89B 189B 73.9B 923B 73.21B 71.63B 3,192B EV / Sales 2026 *
3.39x
EV / Sales 2027 * 2.83x
Free-Float
98.11%
Yield 2026 *
-
Yield 2027 * -
1 day+0.84%
1 week+0.36%
Current month+3.80%
1 month+9.43%
3 months+24.32%
6 months+15.37%
Current year+19.14%
1 week 114.5
Extreme 114.505
119.13
1 month 110.56
Extreme 110.56
119.6
Current year 89.25
Extreme 89.25
119.6
1 year 69.7
Extreme 69.695
119.6
3 years 50.27
Extreme 50.27
119.6
5 years 50.27
Extreme 50.27
119.6
10 years 50.27
Extreme 50.27
153.15
Manager TitleAgeSince
Chief Executive Officer 58 25/06/2025
Director of Finance/CFO 57 03/05/2026
President 62 04/06/2023
Director TitleAgeSince
Chairman 59 25/06/2025
Director/Board Member 72 19/01/2015
Director/Board Member 64 19/01/2015
Date Insider Type Main position Quantity % Market Cap.
16/07/26 Free

EVP & Chief Scientific Officer

46,244 0.0231%
16/07/26 Free

Chairperson

104,772 0.0524%
16/07/26 Free

Chief Executive Officer

184,376 0.0923%
Change 5-day change 1-year change 3-year change Capi.($)
+0.84%+0.36%+67.62%+84.46% 23.51B
+0.63%-3.06%+16.50%-10.12% 66.74B
+1.23%+2.80%+38.09%+200.66% 53.32B
+10.08%+51.80%+51.80%+51.80% 48.12B
-1.32%-7.38%-57.37%-56.96% 38.25B
+0.78%-1.84%+53.73%-25.20% 29.85B
-5.17%-12.54%+58.33%-55.63% 21.45B
-1.21%+1.12%+0.90%+164.17% 19.97B
+1.31%+3.24%+81.47%+157.97% 16.47B
-0.22%-0.95%+62.78%+123.12% 16.38B
Average +0.70%-0.57%+37.38%+63.43% 33.41B
Weighted average by Cap. +1.40%+0.06%+30.72%+54.70%

Financials

2026 *2027 *
Net sales 5.75B 5.05B 4.7B 4.31B 8.1B 554B 8.22B 55.76B 21.78B 272B 21.58B 21.11B 941B 6.21B 5.45B 5.07B 4.65B 8.74B 598B 8.87B 60.19B 23.51B 294B 23.29B 22.79B 1,016B
Net income 426M 375M 348M 320M 601M 41.06B 610M 4.14B 1.62B 20.19B 1.6B 1.57B 69.8B 1.59B 1.4B 1.3B 1.19B 2.24B 153B 2.28B 15.44B 6.03B 75.36B 5.98B 5.85B 261B
Net Debt -4.01B -3.52B -3.27B -3B -5.64B -386B -5.73B -38.86B -15.18B -190B -15.04B -14.72B -656B -5.93B -5.21B -4.84B -4.44B -8.35B -571B -8.48B -57.49B -22.46B -281B -22.25B -21.77B -970B
Logo Incyte Corporation
Incyte Corporation specializes in the research & development of therapeutic products mainly intended for the treatment of cancers and inflammatory disorders. Net sales break down by revenue source as follows: - product sales (84.7%); - royalties (12.4%); - income from research and cooperation agreements (2.9%).
Employees
2,844
Date Price Change Volume
24/07/26 US$117.67 +0.84% 1,207,106
23/07/26 US$116.69 +0.78% 956,259
22/07/26 US$115.79 -1.36% 998,480
21/07/26 US$117.39 +1.50% 1,906,845
20/07/26 US$115.65 -1.36% 1,257,145
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
26
Last Close Price
117.67USD
Average target price
114.55USD
Spread / Average Target
-2.66%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. INCY Stock